tacrine has been researched along with Chronic Disease in 5 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " This article reviews basic approaches in pharmacoeconomics; current knowledge of costs related to dementia; assessment of quality of life in patients with cognitive impairment; models of relationships among degree of cognitive impairment, caregiver burden, and health care utilization; existing pharmacoeconomic guidelines for drug studies; pharmacoeconomic studies of tacrine, a drug used in Alzheimer disease; and further work needed to advance the critical area of pharmacoeconomic studies in dementia." | 3.69 | Pharmacoeconomics of dementia. ( Whitehouse, PJ, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, X | 1 |
| Tian, J | 1 |
| Sun, S | 1 |
| Dong, Q | 1 |
| Zhang, F | 1 |
| Zhang, X | 1 |
| Shu, XJ | 1 |
| Liu, W | 1 |
| Zhang, L | 1 |
| Yang, R | 1 |
| Yi, HL | 1 |
| Li, CL | 1 |
| Ye, YJ | 1 |
| Ai, YX | 1 |
| Zhao, Q | 1 |
| Murakami, Y | 1 |
| Tohda, M | 1 |
| Obi, R | 1 |
| Shimada, Y | 1 |
| Matsumoto, K | 1 |
| Hanus, H | 1 |
| Tůtma, I | 1 |
| Zapletálek, M | 1 |
| Fusek, J | 1 |
| Hrdina, V | 1 |
| Whitehouse, PJ | 1 |
5 other studies available for tacrine and Chronic Disease
| Article | Year |
|---|---|
(-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model.
Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Chronic Di | 2016 |
Effect of bis(7)-tacrine on cognition in rats with chronic cerebral ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; Chronic Disease; Cognition; Hippocampus; Male; Maze Learning; Ne | 2012 |
Chotosan, a kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice.
Topics: Acetylcholinesterase; Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Cere | 2007 |
Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induced; Euph | 1991 |
Pharmacoeconomics of dementia.
Topics: Alzheimer Disease; Chronic Disease; Clinical Trials, Phase III as Topic; Cognition Disorders; Costs | 1997 |